鶹ýɫƬ

Award

Taylor’s career began as a med school detour

She has won the 2022 Herbert Tabor Research Award
Nivedita Uday Hegdekar
Dec. 23, 2021

’s career spans over 50 years of groundbreaking research, accolades and accomplishments. But she never intended to follow this path.

Susan Taylor

As a freshman at the University of Wisconsin, Taylor dreamed of becoming a physician. Charles Sorum, her chemistry professor, solidified her foundation in the field. “He was a big influence in my life and inspired me to major in chemistry, despite it being an unconventional choice for a woman in the 1960s,” Taylor said.

During her senior year, Taylor’s fiancé accepted a job at the National Institutes of Health in Maryland. Having missed the Johns Hopkins Medical School deadline, she applied to the Hopkins graduate school, where she completed doctoral research on lipids with Edward Heath and became a biochemist.

“I still had my heart set on medical school,” Taylor said. “However, my husband accepted a position in Cambridge, England, so I decided to hold off … for a few more years.”

As a postdoc with at the Laboratory of 鶹ýɫƬ Biology, Taylor found her life’s calling — protein chemistry and structural biology — and shelved her med school plans for good.

“My two years in Cambridge taught me how to think about science across disciplines and how to approach research problems as an interdisciplinary challenge,” she said.

Taylor returned to the U.S. as a postdoctoral fellow at the University of California, San Diego, where she remained and is now a distinguished professor in two departments: chemistry and biochemistry and pharmacology.

For her excellence in research and contributions to the scientific community, Taylor will receive the 鶹ýɫƬ and 鶹ýɫƬ Biology’s 2022 Herbert Tabor Research Award.

A passionate advocate for interdisciplinary science, especially for training the next generation of scientists, Taylor is especially conscientious about recruiting and mentoring underrepresented students.

She looks back fondly on her professional journey.

“I have had the good fortune of collaborating with so many creative scientists from various disciplines,” she said. “Over the years, we have supported and learned from each other.”

Fascination with a signaling molecule

When Susan Taylor was a postdoctoral fellow at the fledgling University of California, San Diego, her advisor, , introduced her to cAMP-dependent protein kinase, or PKA, a signaling molecule that regulates glycogen, lipid metabolism and many other things within cells.

“I became fascinated with this highly allosteric enzyme and decided to characterize it further,” Taylor said. She and PKA became lifelong partners.

In her own lab, Taylor led studies that elucidated the structure and function of PKA. Following identification of active site residues in the catalytic and regulatory subunits, she and her collaborators solved the structure of the PKA C-subunit in 1991 - the first protein kinase structure. She subsequently solved structures of higher complexity, culminating in full-length functionally nonredundant holoenzymes.

Unraveling the dynamics and allosteric signaling and demonstrating how these correlate with disease phenotypes has been a continuing theme of the Taylor lab. Most recently, using high-resolution imaging in retina and brain, she has further defined isoform specificity and, in particular, has focused on the previously uncharacterized Cb isoform, which accounts for about 50% of PKA signaling in brain.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nivedita Uday Hegdekar

Nivedita Uday Hegdekar is a recent Ph.D. graduate in biochemistry and molecular biology from the University of Maryland, Baltimore.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Meet the 2025 SOC grant awardees
Outreach

Meet the 2025 SOC grant awardees

Aug. 15, 2025

Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

In memoriam: William S. Sly
In Memoriam

In memoriam: William S. Sly

Aug. 11, 2025

He served on the 鶹ýɫƬ and 鶹ýɫƬ Biology Council in 2005 and 2006 and was an ASBMB member for 35 years.

ASBMB committees welcome new members
Society News

ASBMB committees welcome new members

Aug. 7, 2025

Members joined these committees: Education and Professional Development, Maximizing Access, Meetings, 鶹ýɫƬ, Public Affairs Advisory, Science Outreach and Communication, Student Chapters and Women in Biochemistry and 鶹ýɫƬ Biology.